Clinical Trial Update: Intravitreal Macugen for Ischaemic Diabetic Macular Oedema [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravitreal pegaptanib (Macugen) for ischaemic diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: University of Oxford | Conditions: Diabetic Macular Oedema | Phase 4 | Status: COMPLETED